Rankings
▼
Calendar
AQST FY 2024 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AQST
Aquestive Therapeutics, Inc.
$431M
FY 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$58M
+13.8% YoY
Gross Profit
$40M
69.0% margin
Operating Income
-$31M
-53.5% margin
Net Income
-$44M
-76.7% margin
EPS (Diluted)
$-0.51
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$36M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$101M
Total Liabilities
$162M
Stockholders' Equity
-$60M
Cash & Equivalents
$72M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$58M
$51M
+13.8%
Gross Profit
$40M
$30M
+33.4%
Operating Income
-$31M
-$15M
-103.8%
Net Income
-$44M
-$8M
-460.8%
← Q4 2023
All Quarters
Q1 2024 →